Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
GRHPR encodes an enzyme with hydroxypyruvate reductase, glyoxylate reductase, and D-glycerate dehydrogenase enzymatic activities. Zusätzlich bieten wir Ihnen Glyoxylate Reductase/hydroxypyruvate Reductase Antikörper (60) und Glyoxylate Reductase/hydroxypyruvate Reductase Proteine (7) und viele weitere Produktgruppen zu diesem Protein an.
Showing 3 out of 5 products:
GRHPR was genotyped in Japanese patients with PH2 and all GRHPR mutations described to date were reviewed in terms of geographic and ethnic association
Our findings suggest that the GRHPR defect in noncancerous tissues may represent an independent predictor of poor survival for hepatocellular carcinoma patients after curative resection
GRHPR directly interacts with SVCT1 (zeige SVCT1 ELISA Kits).
the GRHPR gene may have a role in primary hyperoxaluria type 2 in a Japanese patient [case report]
These data suggested that GRHPR might exert its pro-apoptosis function in intestinal epithelial cells. Thus, GRHPR might play an important role in regulating IECs apoptosis, and might be a potential therapeutic target for Crohn's disease.
data indicate a species-specific regulation by PPARalpha (zeige PPARA ELISA Kits) of GRHPR, a key gene of the glyoxylate cycle
This gene encodes an enzyme with hydroxypyruvate reductase, glyoxylate reductase, and D-glycerate dehydrogenase enzymatic activities. The enzyme has widespread tissue expression and has a role in metabolism. Type II hyperoxaluria is caused by mutations in this gene.
, glyoxylate reductase/hydroxypyruvate reductase
, Glyoxylate reductase/hydroxypyruvate reductase
, uncharacterized protein LOC494855